EUVIMEDEUVIMED entdecken
Crossref

miR‐148a‐3p mitigation of coronary artery disease through PCSK9/NF‐κB inhibition of vascular endothelial cell injury

Jiong Tang, Menghuai Ma, Fan Liu, Xiaomei Yin, Haotian Shi, Qing Li, Kai Yang, Mengyue Yu

Journal of Biochemical and Molecular Toxicology · 2024

DOI: 10.1002/jbt.70011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2024. Verfasst von Jiong Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, Affiliated Cardiovascular Hospital of Kunming Medical Universit…. Hauptthemen laut MEDLINE: MicroRNAs, NF-kappa B, Coronary Artery Disease, Proprotein Convertase 9. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Yunnan Province Medical Leading Talent Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronary artery disease (CAD) causes myocardial ischemia, narrowing or occlusion of the lumen. Although great progress has been made in the treatment of CAD, the existing treatment methods do not meet the clinical needs, so it is urgent to find new treatment methods. The aim of this study was to investigate the mechanism of action of miR‐148a‐3p in alleviating CAD by inhibiting vascular endothelial cell injury and to provide new ideas for the treatment of CAD. A cell model was constructed by lipopolysaccharide (LPS) induction of vascular endothelial cells, and a CAD rat model was established by a high‐fat diet and intraperitoneal injection of posterior pituitary hormone. Relevant indices were detected by RT‐qPCR, ELISA, Western blot, MTT, and flow cytometry. The results indicate that in LPS‐induced vascular endothelial cell assays, miR‐148a‐3p inhibited the upregulation of PCSK9, thereby suppressing the NF‐κB signaling pathway and promoting vascular endothelial cell proliferation. Overexpression of PCSK9 and the addition of NF‐κB signaling pathway activator increased vascular endothelial cell apoptosis. In animal experiments, miR‐148a‐3p alleviated the symptoms of CAD rats, whereas overexpression of PCSK9 promoted apoptosis and increased atheromatous plaque area in CAD rats. In conclusion, miR‐148a‐3p inhibits the NF‐κB signaling pathway through downregulation of PCSK9, thereby protecting vascular endothelial cells and alleviating CAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsNF-kappa BCoronary Artery DiseaseProprotein Convertase 9AnimalsRatsMaleHumansEndothelial CellsSignal TransductionApoptosisRats, Sprague-DawleyHuman Umbilical Vein Endothelial CellsLipopolysaccharides

Stichwörter der Autor:innen

NF‐κBPCSK9coronary artery diseaseinflammationmiR‐148a‐3p

Substanzen

MicroRNAsNF-kappa BProprotein Convertase 9MIRN148 microRNA, humanPCSK9 protein, ratPCSK9 protein, humanLipopolysaccharides

Autor:innen und Institutionen

  • Department of Cardiology, Fuwai Yunnan Hospital, Chinese Academy of Medical Sciences, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, China.
  • Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical Colleg, Beijing, China.

Förderung

  • Yunnan Province Medical Leading Talent Fund

Zitieren

APA

Tang, J., Ma, M., Liu, F., Yin, X., Shi, H., Li, Q., Yang, K., & Yu, M. (2024). miR‐148a‐3p mitigation of coronary artery disease through PCSK9/NF‐κB inhibition of vascular endothelial cell injury. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70011

Vancouver

Tang J, Ma M, Liu F, Yin X, Shi H, Li Q, et al. miR‐148a‐3p mitigation of coronary artery disease through PCSK9/NF‐κB inhibition of vascular endothelial cell injury. Journal of Biochemical and Molecular Toxicology. 2024. doi:10.1002/jbt.70011

BibTeX
@article{Tang2024,
  author = {Tang, Jiong and Ma, Menghuai and Liu, Fan and Yin, Xiaomei and Shi, Haotian and Li, Qing and Yang, Kai and Yu, Mengyue},
  title = {miR‐148a‐3p mitigation of coronary artery disease through PCSK9/NF‐κB inhibition of vascular endothelial cell injury},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2024},
  doi = {10.1002/jbt.70011}
}
Kostenlos starten →